Description
Speakers: Dean McKay, PhD, ABPP
CEU(s) Available: 1.0 ACE Event BACB CEUs
Duration: 1 – 60 minute sessions
Modality: On-demand, video, CEU certificates generated automatically
Abstract: Overvalued ideation (OVI) is a known breakdown in cognitive processes associated with obsessive compulsive disorder (OCD) and several other conditions. The nature of this specific clinical manifestation is that it is close to delusional processes, and placed on a dimension from frank acknowledgment of the unreasonableness of symptoms on one end, to outright thought disorder on the other. Experts in OCD and related disorders typically understand the nature of OVI, but to borrow a famous adage, they know it when they see it even if it eludes a firm definition. There are several assessment measures for OVI, ones that address various aspects of the concept. Assessing this potential complicating feature is important considering that research has shown it can interfere with treatment implementation and outcome. Thus, developing treatment plans when OVI is elevated demands that interventions address both the manifest symptoms and the concurrent complicating facets of this special form of cognitive breakdown. This training will provide attendees with the tools for assessing OVI, and for developing treatment plans that incorporate methods for addressing this complicating factor.
Learning Objective 1: Attendees will be able to identify overvalued ideation (OVI) in clients with a wide range of clinical conditions.
Learning Objective 2: Attendees will be able to assess the severity level of OVI to determine thresholds for it potentially interfering with treatment.
Learning Objective 3: Attendees will be able to formulate interventions that address OVI as well as the primary manifest symptoms.
Dean McKay, PhD, ABPP is Professor, Department of Psychology, Fordham University, is Past President (2018) of the Society for a Science of Clinical Psychology (SSCP), and Past-President (2013-2014) of the Association for Behavioral and Cognitive Therapies (ABCT). He serves as a member of the Advisory Board for Better Living Center for Behavioral Health, which specializes in the treatment of anxiety and obsessive compulsive disorders. Dr. McKay is licensed in New York and Connecticut, a member of the National Registry of Healthcare Psychologists, and board certified from the American Board of Professional Psychology (ABPP) in both Cognitive-Behavioral and Clinical Psychology. He has edited or co-edited 22 books, published over 350 journal articles and book chapters, and given over 300 presentations at scientific organizations. In addition to his work on the Advisory Board of Better Living, he is also on the Scientific Advisory Board of the International Obsessive Compulsive Disorder Foundation (IOCDF). Further, he is also a member of the Psychology of Pandemics Workgroup, an international consortium of researchers examining stress-related psychopathology associated with pandemics that was formed in February 2020. Dr. McKay is a Fellow of the American Psychological Association, Association for Psychological Science, and Association for Behavioral and Cognitive Therapies. His research has been primarily obsessive-compulsive and related disorders, anxiety disorders, the role of disgust in psychopathology, and misophonia (selective sound sensitivity), as well as professional issues in the delivery of evidence-based interventions. He has also provided professional consultation and treatment internationally.
